Jonathan Livny
About Jonathan Livny
Jonathan Livny is an Institute Scientist at the Broad Institute of MIT and Harvard, where he has held various leadership roles since 2019. He specializes in high-throughput sequencing methods and has a strong background in molecular and computational biology.
Work at Broad Institute
Jonathan Livny has held multiple positions at the Broad Institute of MIT and Harvard. He has served as Senior Group Leader since 2019, where he has focused on advancing high-throughput sequencing methods. In 2022, he became Associate Director, contributing to the strategic direction of research initiatives. In 2023, he took on the role of Institute Scientist, further enhancing his involvement in cutting-edge scientific research. His work at the Broad Institute emphasizes making high-throughput sequencing methods accessible to the broader research community.
Education and Expertise
Jonathan Livny earned his Doctor of Philosophy (Ph.D.) in Cell and Molecular Biology from the University of Michigan, where he studied from 1998 to 2003. He also holds a Bachelor’s Degree in Cell and Molecular Biology from the University of Wisconsin-Madison, completed between 1994 and 1998. His educational background has provided him with extensive expertise in both molecular and computational biology, enabling him to contribute to interdisciplinary scientific advancements.
Background in Research
Before joining the Broad Institute, Jonathan Livny worked as a Postdoctoral Research Fellow at Tufts University School of Medicine from 2004 to 2007 and at Harvard Medical School from 2007 to 2009. He also served as an Instructor in Medicine at Harvard Medical School for 11 months in 2008-2009. His research background has focused on developing and scaling methods for generating and analyzing high-throughput sequencing data, particularly in the context of infectious diseases.
Contributions to High-Throughput Sequencing
Jonathan Livny has made significant contributions to the field of high-throughput sequencing. He has worked on making these methods widely accessible to the research community, which has facilitated advancements in understanding and treating infectious diseases. His efforts in developing and scaling sequencing methods have had a notable impact on research practices in molecular biology.